The decrease in circulating concentrations of progesterone is the lactogenic trigger in many species. The aim of the present study was to determine the effect of an orally active progestogen, altrenogest, administered in late gestation, on lactogenesis in sows. Gilts were treated with altrenogest (20 mg/d) from d 109 to 112 of gestation (ALT112, n = 6) or d 113 (ALT113, n = 8) or were not treated (control, n = 9). Colostrum production, estimated from the BW gains of the piglets, was measured during 24 h starting at the onset of parturition. Colostrum samples were collected at the onset of parturition until 48 h later. Jugular blood samples were taken from d −8 prepartum until d 3 postpartum. Altrenogest treatment extended the gestation length of ALT113 sows in comparison with control sows (116.3 vs. 114.7 d; P < 0.05). Litter size and litter weight at birth did not differ between groups (P > 0.1). Estimated colostrum yield was not reduced in altrenogest-treated sows compared with control sows (4.20 kg) and tended to be greater in ALT112 (4.73 kg) than in ALT113 sows (3.74 kg; P = 0.09). Altrenogest reduced endogenous progesterone concentrations during the 2 d prepartum in ALT113 relative to control sows (P < 0.05), likely because luteolysis occurred earlier in relation to parturition in ALT113 sows. Altrenogest reduced estradiol-17β concentrations during the 2 d prepartum in ALT113 (P < 0.05) and ALT112 (P < 0.1) sows. Altrenogest treatment did not influence the timing of the prepartum peak of prolactin in relation to parturition. The ALT113 sows had lesser (P < 0.05) concentrations of lactose in plasma and a lesser Na:K ratio in colostrum after parturition than Control and ALT112 sows, indicating that the junctions between their mammary epithelial cells were tighter. Concentrations of colostral IgG in sows that received altrenogest tended to be less than in control sows (P = 0.08). In conclusion, altrenogest administered from d 109 to 112 or 113 of pregnancy did not affect lactogenesis in sows, possibly because the treatment delayed farrowing and main hormonal changes without affecting the relative chronology of these changes.
INTRODUCTION
Colostrum provides newborn piglets with energy, immunoglobulins, and growth factors (reviews: Xu et al., 2000; Rooke and Bland, 2002; Le Dividich et al., 2005) . Failure of piglets to achieve an adequate intake of colostrum is likely an underlying cause of the majority of deaths in early postnatal life (Dyck and Swierstra, 1987; Edwards, 2002) . Colostrum intake by piglets depends in part on their ability to extract colostrum from teats but also on the ability of sows to produce a high yield of colostrum (Hoy et al., 1997; Devillers et al., 2007) . Therefore, to reduce early mortality rate in pigs, it is necessary to better understand the endocrine control of lactogenesis in sows. Progesterone withdrawal is a trigger of lactogenesis in numerous species, including rats and humans (Kuhn, 1969; Neville et al., 2001) . In swine, de Passillé et al. (1993) reported a reduced growth rate of piglets from sows that had greater plasma concentrations of progesterone just after parturition. Furthermore, Foisnet et al. (2010) showed that sows producing very low colostrum yield tended to have greater prepartum progesterone concentrations in plasma. In contrast, relatively great concentrations of progesterone associated with increased concentrations of estrogens in late pregnancy seem to allow the IgG transfer from plasma to mammary secretions (Barrington et al., 2001) . The aim of the present study was to evaluate the effects of an orally active progestogen, altrenogest, administered to sows in late gestation on colostrum yield and colostral IgG concentrations.
MATERIALS AND METHODS
Sows and piglets were reared in compliance with French regulations for the humane care and use of animals in research.
Animals
Twenty-three Landrace × Large White gilts were inseminated with semen from Piétrain boars. During pregnancy, and until the day of farrowing (d 0), gilts were fed 2.5 kg daily of a conventional gestation diet containing 13.3 MJ of DE/kg, 13.5% CP, and 0.5% lysine. Feed was provided in 2 equal meals at 0900 and 1400 h. After farrowing, the sows received a conventional lactation diet containing 13.7 MJ of DE/kg, 17.4% CP, and 0.8% lysine. They were offered 2.5 kg of this diet on d 1. Afterwards, the feed supply was increased by 1 kg/d until d 4 and then by 500 g daily until ad libitum feeding (around d 8). Sows were moved from the gestation to the farrowing room (2 × 2.5 m) at 99 ± 1 d of gestation. They were assigned to 1 of 3 experimental groups: sows receiving altrenogest (Regumate; Janssen-Cilag, Issy-les-Moulineaux, France) from d 109 to 112 of pregnancy (ALT112, n = 6), sows receiving altrenogest from d 109 to 113 of pregnancy (ALT113, n = 8), and sows receiving no treatment (control, n = 9). Altrenogest treatment was given at 0900 h in the morning meal as a top-dressing of 20 mg/d.
During the first 24 h postpartum, the original litter was kept with the sow. Beyond 24 h, litters were standardized to 12 piglets by crossfostering within treatment groups. Throughout lactation, piglets had no access to creep feed. They were weaned at 25 ± 1 d of age. Water was freely available to sows and piglets throughout the experimental period.
The sows were weighed just before being moved to the farrowing room, as well as on d 112 of pregnancy and at weaning. Their backfat thickness was measured ultrasonically (Sonolayer SAL-32B, Toshiba, Tokyo, Japan) at the 10th rib on each side, 65 mm from the midline, on these same days. During established lactation, piglets were weighed at 7 d of age and at weaning.
Farrowing Supervision
Parturition was not induced. During parturition, interventions were kept to a minimum. Two milliliters of oxytocin (10 IU/mL; Ocytocem, CEVA Santé Animale, Libourne, France) was injected, and piglets were manually extracted, only if necessary. Birth of the first piglet was designated as T0. Farrowing duration was estimated as the time between births of the first and last piglets. Each piglet was weighed individually at birth and 24 h after the onset of farrowing (T24). Time between birth and the first suckling was recorded for each piglet. When this latency exceeded 40 min, piglets were assisted for their first suckle. No additional help or care was given before T24.
Surgery and Samplings
Blood Sampling. At 99 ± 1 d of pregnancy, a catheter was inserted through a collateral vein in the right jugular vein, under general anesthesia, as described previously (Mosnier et al., 2009) . From d 105 of pregnancy to d 3 after farrowing, 15 mL of blood was collected daily at 0830 h. Additional samples (10 mL) were collected at 1430 and 2030 h from d 112 of pregnancy to d 1, as well as on d 2 and 3, and after the birth of the first piglet (T0). All blood samples were partly collected in heparinized tubes kept on ice and partly in tubes containing no anticoagulant. Heparinized samples were immediately centrifuged to collect plasma, whereas samples without anticoagulant were kept at ambient temperature for 4 h and stored overnight at 4°C before centrifugation. All samples were centrifuged for 10 min at 2,600 × g at 4°C. Plasma and serum were stored at -20°C until analyses.
Colostrum and Milk Sampling. Colostrum was collected just after the birth of the first piglet, and then 6, 12, 24, 36, and 48 h later (T0, T6, T12, T24, T36, and T48, respectively). Thirty-five milliliters of colostrum were collected at T0, T24, and T48 and 15 mL at T6, T12, and T36. Colostrum was collected from 6 to 8 teats located in the anterior, middle, and posterior parts of the udder. It was filtered through gauze tissue and stored at −20°C. From T6 onward, 0.5 mL of oxytocin (10 IU/mL; CEVA Santé Animale) was administered intravenously to induce colostrum ejection. Milk (35 mL) was collected at 21 ± 1 d of lactation after an intramuscular injection of 20 IU of oxytocin.
Biological Analyses
Concentrations of all components in blood, colostrum, or milk were determined in duplicate, except for IgG concentrations, which were analyzed in triplicate.
Hormone Assays in Plasma or Serum. Plasma concentrations of cortisol, progesterone, estradiol-17β, and IGF-I were measured by RIA using commercial kits (references IM1841, IM1188, A21854, and A15729, respectively; Beckman Coulter, Roissy CDG, France). The intra-and interassay CV were, respectively, 5.8 and 9.0% for progesterone, 6.0 and 7.7% for estradiol-17β, and 5.6 and 8.0% for cortisol. The assay sensitivity was 0.1 ng/mL for progesterone, 6 pg/mL forestradiol-17β, and 6.2 ng/mL for cortisol. Prolactin concentrations in serum were determined by a homologous double-antibody RIA (Robert et al., 1989 ) within a single assay. The prolactin intra-assay CV was 4.8%, and average sensitivity was 1.8 ng/mL. Plasma IGF-I concentrations were measured within a single assay. The intra-assay CV was 9.6%, and the assay sensitivity was 4.4 ng/mL.
The day of blood sampling was calculated relatively to the day of farrowing (d 0) a posteriori. The first day of alternogest treatment, which was d 109 of gestation, corresponded to approximately d −7 prepartum (−7.3 ± 0.2 d). Steroid and IGF-I concentrations were measured once before the onset of altrenogest treatment (on d −8), then on serial samplings from d −2 to 2, and at T0. Prolactin concentrations were measured from d −2 to 2, and at T0.
Metabolite Assays in Plasma. Glucose, NEFA, lactate, urea, and creatinine concentrations in plasma were determined in premeal blood samplings obtained at 0830 h. Automated enzymatic methods using an automatic analyzer (Konelab20i, Themo, Cergy, France) were used to determine plasma concentrations of glucose (reference 61269, bio-Mérieux, Marcy l'Etoile, France), NEFA (NEFA C reference 754664, Wako, Dardilly, France), lactate (lactate PAP, reference 61192, bio-Mérieux), urea (Urea unimate 5, reference 07-3685-6, Roche, Neuilly-sur-Seine, France), and creatinine (créatinine cinétique reference 61162, bio-Mérieux). Metabolite concentrations were assayed daily from d −8 to 2.
IgG in Plasma. Immunoglobulins G were assayed in plasma using a pig IgG ELISA Quantification Kit (reference E100-104, Bethyl, Montgomery, TX) according to a described previously method (Devillers et al., 2004a) . Plasma samples were diluted at 1:30,000 or 1:40,000. The intra-assay CV was 2.9%, and the interassay CV was 10.0%.
Lactose in Plasma. After deproteinization of plasma with perchloric acid and neutralization with potassium hydroxide, lactose was assayed using an enzymatic method (reference 01766303, Lactose/d-galactose test combination, R-Biopharm, Darmstad, Germany). The assay sensitivity was 10.2 mg/L. Lactose concentrations were determined from d −6 until 3 postpartum. Because lactose is exclusively synthesized by the mammary gland, lactose in plasma was used to evaluate the permeability of the mammary epithelium.
Assays in Colostrum and Milk
Colostrum Composition. Crude contents in colostrum (GE, DM, ash, CP, lactose) were assayed at T0, T24, and T48. Lipid contents were assayed at T0 and T24 only. Concentrations of IgG were measured in colostrum at T0, T24, and T48. Contents of Na and K were assayed at T0, T6, T12, T24, T36, and T48. Nitrogen was determined according to the method of Dumas based on sample pyrolysis and direct determination of N 2 using an automatic device (Leco FP-428, Leco Corporation, St. Joseph, MO). Crude proteins were estimated to be N × 6.38 (Gordon and Whittier, 1965) . Total lipids were measured according to the Gerber method (AOAC, 1990 ). Gross energy was measured using an adiabatic bomb calorimeter (IKA, C5000, Staufen, Germany). Lactose in colostrum was assayed using an enzymatic method (reference 01766303, Lactose/d-galactose test combination, R-Biopharm). Contents of Na and K were determined with a Konelab 20i multichannel analyzer with ion selective electrodes after dilution with a diluent for urine (reference 980303, Thermo Electron Corporation, Cergy Pontoise, France). The Na:K ratio in colostrum, which is known to be inversely correlated with the integrity of the mammary epithelium during lactation (Sørensen et al., 2001) , was used as a second indicator of the permeability of the mammary epithelium.
IgG in Colostrum. Immunoglobulin G assays in whole colostrum were performed as in plasma. Colostrum samples were diluted at 1:500,000, and each dilution was measured twice in triplicate. The intra-assay CV was 2.9%, and the interassay CV was 8.3%.
Estimation of Colostrum and Milk Production
Colostrum intake by individual piglets between birth and T24 was estimated from piglet BW variation, according to an equation developed in the present experimental herd (Devillers et al., 2004b) ], where CI = colostrum intake (g); BWB = birth weight (kg); BW = BW at T24 (kg), t = time elapsed between the first and the second weighing (min), and tFS = the interval between birth and first suckling (min). Colostrum production by the sow during the 24 h after the onset of parturition was calculated as the sum of intakes by each piglet of the litter. Mean daily milk production from d 1 to 21 was estimated using piglet ADG according to Noblet and Etienne (1989) .
Statistical Analyses
Data, except mortality rate, were analyzed by ANO-VA using the MIXED procedure (SAS Inst. Inc., Cary, NC). The sows or the litter represented the experimental unit in the model, which included treatment (control, ALT112, or ALT113) or altrenogest (control vs. ALT112+ALT113) as the main effect. Time-related variations in concentrations of hormones, metabolites, and IgG in blood were analyzed using the procedure for repeated measurements. Colostrum or milk composition as well as IgG and electrolytes in colostrum were analyzed within sampling day. When the effect of treatment or sampling time was significant, means were separated by F-protected LSD. Mortality rate of piglets was analyzed using Fisher's exact test.
RESULTS

Sow Characteristics
At d 112 of pregnancy, ALT113 sows were lighter (P < 0.01) than sows from the 2 other groups, but backfat thickness did not differ between experimental groups (Table 1) . Gestation length was longer in ALT113 (P < 0.05) and ALT112 (P < 0.1) than in control sows. Farrowing duration did not differ between groups (P > 0.1) and averaged 200 ± 19 min.
Piglet and Litter Characteristics and Litter Performance During Early Lactation
The number of piglets born alive and stillborn averaged 14.4 ± 0.7. Characteristics of the litters nursed during d 1 postpartum, in terms of the number of piglets, the total litter weight, and the mean piglet BW within litter, did not differ between groups (P > 0.1; Table 2 ). Mean piglet BW gain between birth and T24 averaged 110 ± 5 g and was not influenced by treatments (P > 0.1). Litter weight gain between T0 and T24 and estimated colostrum yield did not differ between control and altrenogest-treated sows but tended to be greater in ALT112 than in ALT113 litters (P < 0.1). The time elapsed between birth and the first suckling by newborn piglets was longer in ALT113 than in control and ALT112 sows (P < 0.05). Rate of stillbirth did not differ between the 3 groups and averaged 3.8 ± 1.6%.
Colostrum Composition
At T0 and T24, there was no difference in colostrum composition between treatments (P > 0.1; Table 3 ). At T48, colostrum content of DM was less (P = 0.01) and protein and GE contents tended to be less (P < 0.1) in ALT113 than in control and ALT112 sows (Table  3) . Concentrations of IgG in colostrum were greater at T0 than at T24 and T48 (P < 0.001; Figure 1 ). Sows treated with altrenogest (ALT112+ALT113) tended to have less colostral IgG than control sows (P = 0.08).
Sow Endocrine and Metabolic Status
At the birth of the first piglet (T0), circulating concentrations of progesterone, estradiol-17β, or prolactin did not differ between groups of sows (P > 0.1).
Progesterone. There was a treatment × sampling time interaction (P < 0.05; Figure 2A ). Plasma concentrations of progesterone did not differ between groups on d −8. On d −2, the concentrations had started to decline at 0830 h in ALT113 sows and only at 2030 h in Means within a row with different superscripts differ (P < 0.05).
x,y
Means within a row with different superscripts tend to differ (P < 0.1). Means within a row with different superscripts differ (P < 0.05).
Means within a row with different superscripts tend to differ (P < 0.1). Prolactin. Serum concentrations of prolactin averaged 13.9 ± 2.0 ng/mL on d −2, increased to reach maximal values on d 0, then declined to an average value of 28.3 ng/mL at d 2 ( Figure 2C ). Concentrations of prolactin did not differ at any time between treatment groups (P > 0.1). Means within a row with different superscripts differ (P < 0.05). Cortisol. Plasma concentrations of cortisol did not differ between treatment groups at d −8 and from d −2 to 1 (P > 0.1; data not shown). Concentrations of cortisol were 28.1 ± 3.8 ng/mL on d −2, 29.9 ± 2.4 ng/ mL on d −1, and 38.8 ± 3.5 ng/mL on d 0.
Metabolites and IGF-I. Preprandial concentrations of glucose, NEFA, lactate, creatinine, and urea fluctuated over time but did not differ between groups of sows (P > 0.1; data not shown). Plasma concentrations of IGF-I remained at nadir until farrowing and then increased; they did not differ between treatment groups (P > 0.1).
Plasma IgG. There was a treatment × sampling time interaction for IgG concentrations in plasma (P < 0.001; Figure 3 ). Concentrations of IgG decreased between d −8 and −2 in control and ALT112 sows (P < 0.05), whereas they increased in ALT113 sows (P < 0.05). At d 0, concentrations were less than at d −8 in control and ALT112 sows (P < 0.05), but not in ALT113 sows.
Indicators of Mammary Epithelium Tightness
Lactose in Plasma. There was a treatment × time interaction for plasma lactose concentrations (P < 0.01; Figure 4A ). In control and ALT112 sows, lactose concentrations increased during d 0 between 0830 and 1430 h and then remained greater on d 2 and 3 than before d 0. In ALT113 sows, there was no increase in plasma lactose concentrations. From d 0 to 3, the ALT113 sows had lesser concentrations of lactose than sows from the 2 other groups (P = 0.03).
Na:K Ratio in Colostrum. The Na:K ratio was smaller in ALT113 than in ALT112 and control sows (P < 0.001 and P = 0.02, respectively; Figure 4B ). The ratio tended to be greater in ALT112 than in control sows (P = 0.06). Across treatment, the Na:K ratio increased between T0 and T6, then decreased and remained smaller from T12 to T48 compared with T0.
Performances During Lactation
On d 1 after standardization, litter size did not differ between experimental groups (P > 0.1), but ALT112 litters were heavier than ALT113 litters (P = 0.03; Table 4). Mean piglet BW at weaning, and ADG of piglet from d 1 to weaning, did not differ between groups (P > 0.1). Estimated daily milk yield between d 1 and 21 was not influenced by treatment (P > 0.1), and no differences were observed in milk composition (DM, ash, proteins, lactose, and GE contents) on d 21 of lactation (P > 0.1; data not shown). 
DISCUSSION
Altrenogest was administered to sows in late gestation to study the effect of increased amount of progesteronelike activity on lactogenesis. The treatment was ended by d 112 or 113 of gestation (i.e., before the expected day of parturition). This timing prevented adverse effects on neonatal survival, as reported after progesterone or progestogen administration until d 114 or 115 (Sherwood et al., 1978; Gooneratne et al., 1979 ; Guth- Means within a row with different superscripts differ (P < 0.05). Litter size on d 1 (after standardization of litter size) was introduced as a covariate. rie et al., 1987) . Consistently, no difference in stillbirth rate was observed between groups in the present study. Altrenogest treatment until d 113 extended gestation length by more than 1 d, which is in agreement with previous findings (Sherwood et al., 1978; Guthrie et al., 1987) . At the start of the experiment, sows differed in BW, the ALT113 sows being lighter than sows from the 2 other groups. Nevertheless, the lack of significant differences in plasma metabolites and IGF-I indicated that sows were similar from a metabolic standpoint.
Altrenogest treatment did not influence litter weight gain and estimated colostrum yield during the first 24 h postpartum. A slight difference in colostrum yield was observed between the 2 groups of sows that received altrenogest, and litter BW gain and colostrum yield tended to be greater in ALT112 than in ALT113 sows. This trend in colostrum yield could be attributed to a difference in litter characteristics rather than to the 1-d difference in treatment duration. Indeed, although litter size, litter weight, and average piglet birth weight did not differ between groups, piglets from ALT113 sows needed more time to successfully suckle for the first time than piglets from ALT112 sows. A shorter average time between birth and first suckling may reflect reduced litter vitality and thus reduced capacity of colostrum ingestion by the litter (Devillers et al., 2007) , leading to an underestimation of the capacity of colostrum production by ALT113 sows.
Altrenogest treatment reduced plasma concentrations of endogenous progesterone in ALT113 compared with control sows during the 2 d prepartum. This result might indicate that luteolysis started earlier, in relation to the onset of farrowing, in ALT113 sows, as previously suggested in sows which were treated with altrenogest from d 110 to 115 of pregnancy (Kirkwood et al., 1985) . Alternatively, decreased concentrations of endogenous progesterone could reflect a decreased secretion of progesterone by corpora lutea due to the inhibitory action of altrenogest on LH secretion. This anterior pituitary gland hormone is known as the main luteotrophic hormone, although its role in the peripartal period has not been demonstrated (Taverne, 2001) . Profiles of prolactin did not differ between the 3 groups of sows, indicating that the prepartum peak of prolactin was delayed, in relation to insemination, in ALT113 sows. In contrast, Taverne et al. (1982) reported that the prepartum peak of prolactin occurred simultaneously with increased circulating concentrations of progesterone in sows treated with progesterone in late pregnancy. This latter observation was obtained on 3 sows only and was not consistent with knowledge on endocrine regulation of prolactin secretion. Indeed, progesterone has been reported to inhibit the stimulatory action of estradiol-17β on prolactin release by lactotroph cells in numerous species (Pétridou et al., 2001) . In the present study, therefore, it is likely that altrenogest treatment until d 113 inhibited prolactin secretion and thereby delayed the prepartum prolactin peak. Altrenogest treatment also reduced concentrations of estradiol-17β during the 2 d before farrowing. The origin and physiological significance of this decrease remain unclear. Because ovarian contribution to circulating concentrations of estradiol-17β is minor in late pregnancy, the inhibitory action of altrenogest on LH secretion is unlikely to be involved. Nevertheless, this reduction in estradiol-17β did not reduce the amplitude of the prepartum peak of prolactin.
Progesterone withdrawal is necessary for lactose synthesis by mammary epithelial cells and closure of cell junctions in the mammary epithelium, 2 events required for copious milk production (Saint et al., 1984; Itoh and Bissell, 2003) . Moreover, reduced lactose synthesis and looser mammary epithelium tight junctions, which are related to delayed changes in progesterone and prolactin concentrations before parturition, were associated with a poor colostrum yield in swine (Foisnet et al., 2010) . In the present experiment, altrenogest had no effect on lactose concentrations in colostrum. The 2 variables used to assess mammary epithelium integrity, lactose concentrations in plasma and the Na:K ratio in colostrum, indicated that the mammary epithelium was in a tighter state in ALT113 than in control and ALT112 sows, as soon as parturition started. This was well illustrated by the lack of significant increase in lactose in plasma of ALT113 sows, indicating no loss of colostral lactose through disrupted cell junctions. This finding was unexpected as the withdrawal of progesterone is the trigger for tight junction closure in mouse and bovine mammary glands (Nguyen et al., 2001; Quesnell and Schultz, 2007) . The fact that altrenogest did not maintain the opening of tight junctions longer after parturition might mean that altrenogest did not fully mimic the effect of progesterone in the mammary gland. In most vertebrate species, progesterone receptor (PR) is produced from a single gene as 2 receptor isoforms, PR-A and PR-B (Buser et al., 2007) . Genetic targeting experiments in mice have shown distinct biological roles for PR-A and PR-B in vivo; PR-A is important for mediating the actions of progesterone in the uterus and ovary, whereas PR-B is predominant during lactogenesis and lactation in the mammary gland (Schams et al., 2003; Mulac-Jericevic and Conneely, 2004) . In vitro, altrenogest can bind PR-A with a greater affinity than progesterone (McRobb et al., 2008) , and to our knowledge, no published data are available on the affinity of altrenogest for the PR-B isoform. If mainly endogenous progesterone is potent in the mammary gland, the reduced concentrations of progesterone before parturition could explain the tighter mammary epithelium in ALT113 sows. However, our present findings are consistent with observations reported after administration of progesterone, where no adverse effects of exogenous progesterone in late pregnancy were reported on lactose, Na, or K concentrations in sow colostrum (Gooneratne et al., 1979) , or on lactose synthesis in the ewe (Crosby et al., 2005) .
In the 2 studies mentioned above, exogenous progesterone had no adverse effect on swine colostrum compo-sition or on piglet growth rate between birth and 19 d of age (Gooneratne et al., 1979) , or on colostrum yield in the ewe (Crosby et al., 2005) . In these 2 studies, as well as in the present study, progestogen or progesterone treatment extended gestation length. In the present experiment, altrenogest treatment delayed prepartum peaks of prolactin and estradiol-17β, in relation with the onset of gestation. It did not delay spontaneous luteolysis, but the decreased concentrations of endogenous progesterone were largely compensated for by increased concentrations of progesterone or progesteronelike hormones due to the treatment. Thus, we suggest that administration of progestogen or progesterone in late pregnancy does not impair colostrum yield because the treatment delays the hormonal changes naturally occurring before parturition without affecting relative chronology of these changes.
Concentrations of colostral IgG in sows fed altrenogest tended to be less between T0 to T48 relative to control sows. In the ewe, progesterone administered in late pregnancy reduced IgG concentrations in colostrum collected at T0 (Crosby et al., 2005) . In pigs, the uptake of serum IgG by mammary glands could be mediated by a Fc-specific receptor localized on the cellular membrane of mammary epithelial cells, the neonatal Fc receptor (FcRn; Schnulle and Hurley, 2003) , as in ruminants (Barrington et al., 2001) . A role for the decrease in progesterone:estrogen ratio was suggested in the initiation of FcRn activity in the mammary gland of cows, whereas prolactin decreases the expression of the FcRn (Barrington et al., 1999 (Barrington et al., , 2001 . Whether the decreased plasma concentrations of estradiol-17β observed in treated sows limited IgG transfer to colostrum, despite increased concentrations of a progesterone-like molecule, merits further investigation.
Altrenogest treatment until d 113 of gestation altered colostrum/milk composition 2 d after parturition. The colostrum of ALT113 sows contained less DM and tended to have less protein and energy, yet the tendency for less energy had no consequence on piglet growth rate, given that piglet ADG between d 1 and 21 were not different between treatment groups.
In conclusion, altrenogest administered between d 109 and 112 or 113 of pregnancy did not affect lactogenesis in sows. This is likely due to the fact that altrenogest treatment delayed farrowing and main hormonal changes at parturition without affecting the relative chronology of these hormonal changes. Nevertheless, a trend for a reduced transfer of IgG to colostrum was observed, possibly in relation with reduced concentrations of estradiol-17β.
